Trump Media stock hits a wall, banks’ new challenge, and crypto explodes: Markets news roundup
Photo: Javier Ghersi (Getty Images), Rebecca Noble (Getty Images), Alexander Spatari (iStock by Getty Images), Scott Olson (Getty Images), Matteo…
Nvidia to win the race to $4 trillion market cap, experts say
Buy the dip. That was the mindset around chip stocks this week as investors scooped up beaten-down shares, sending Nvidia…
‘Don’t Normalize’ Trump’s Behavior, Warns Mark Cuban, Says It’s An Insult To American Workers To Claim Their Job Could Be Done By A Child
‘Don’t Normalize’ Trump’s Behavior, Warns Mark Cuban, Says It’s An Insult To American Workers To Claim Their Job Could Be…
This Labor Strike Just Cost 10% of Boeing’s Workers Their Jobs
Boeing’s labor strike entered its sixth week on Friday. With 33,000 workers from the International Association of Machinists (IAM) off…
1 Top Cryptocurrency to Buy Before It Soars 700%, According to this Wall Street Executive and Billionaire
It seems that, eventually, everyone changes their tune on Bitcoin (CRYPTO: BTC). One of those people is none other than…
A hot economy is good enough for stocks — and even for rate cuts
This is The Takeaway from today’s Morning Brief, which you can sign up to receive in your inbox every morning…
1 Super Semiconductor ETF That Could Turn $400 Per Month Into $1 Million, With Nvidia’s Help
Nvidia (NASDAQ: NVDA) pioneered the graphics processing unit (GPU) in 1999 to render computer graphics for gaming and multimedia purposes.…
Billionaires Are Buying a BlackRock Index Fund That Could Soar Up to 73,000%, According to Wall Street Experts
In the first half of 2024, the billionaires listed below started positions in BlackRock‘s exchange-traded fund (ETF) that tracks the…
Big tobacco companies reach tentative multibillion-dollar settlement with Canada
TORONTO (AP) — Three large tobacco companies would pay nearly $24 billion to settle a long-running legal battle in Canada,…
mRNA licensing agreements surge 800% amid GSK lawsuits
mRNA-based innovator pharmaceuticals have experienced a massive increase in licensing agreement deal values following success with the technology in Covid-19…
